Sequencing DNA isn’t enough. Genetic sequence must also be translated into medically actionable information.
Invitae has invested heavily in developing Sherloc, an advanced variant classification system that enables objective and reproducible results, a cornerstone of clinically valid and scientifically accurate genetic testing.
We recently published our approach in Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics (ACMG), and hosted a webinar that describes how Invitae:
We believe that our advanced approach to variant classification results in better treatment and care.